Dynavax Technologies [DVAX] vs Zoetis [ZTS] Detailed Stock Comparison

Dynavax Technologies Corporation

NASDAQ
Loading...

Zoetis Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Dynavax Technologies Corporation wins in 7 metrics, Zoetis Inc. wins in 13 metrics, with 0 ties. Zoetis Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Dynavax Technologies Corporation Zoetis Inc. Better
P/E Ratio (TTM) 54.60 19.58 Zoetis Inc.
Price-to-Book Ratio 3.41 15.04 Dynavax Technologies Corporation
Debt-to-Equity Ratio 54.15 279.59 Dynavax Technologies Corporation
PEG Ratio 0.71 2.81 Dynavax Technologies Corporation
EV/EBITDA 60.37 13.96 Zoetis Inc.
Profit Margin (TTM) -13.13% 28.24% Zoetis Inc.
Operating Margin (TTM) 24.77% 34.69% Zoetis Inc.
EBITDA Margin (TTM) 24.77% 34.69% Zoetis Inc.
Return on Equity -7.14% 65.99% Zoetis Inc.
Return on Assets (TTM) 1.20% 15.26% Zoetis Inc.
Free Cash Flow (TTM) $60.16M $2.28B Zoetis Inc.
Dividend Yield N/A 1.21% N/A
1-Year Return 20.90% -53.93% Dynavax Technologies Corporation
Price-to-Sales Ratio (TTM) 5.51 5.26 Zoetis Inc.
Enterprise Value $1.46B $56.75B Zoetis Inc.
EV/Revenue Ratio 4.42 6.00 Dynavax Technologies Corporation
Gross Profit Margin (TTM) 84.82% 70.17% Dynavax Technologies Corporation
Revenue per Share (TTM) $3 $21 Zoetis Inc.
Earnings per Share (Diluted) $-0.37 $6.02 Zoetis Inc.
Beta (Stock Volatility) 0.93 0.97 Dynavax Technologies Corporation
Short % of Float 13.19% 4.06% Zoetis Inc.

Dynavax Technologies Corporation vs Zoetis Inc. Stock Performance Analysis

Loading Price Chart...

DVAX
ZTS

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Dynavax Technologies Corporation0.00%0.13%-1.15%40.40%47.90%0.78%
Zoetis Inc.1.51%-4.46%-31.75%-39.76%-38.95%-38.30%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Dynavax Technologies Corporation20.90%39.64%53.92%-21.40%-49.68%-74.59%
Zoetis Inc.-53.93%-54.80%-55.66%62.09%150.53%150.53%

Performance & Financial Health Analysis: Dynavax Technologies Corporation vs Zoetis Inc.

MetricDVAXZTS
Market Information
Market Cap i$1.82B$49.75B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i2,683,4472,727,710
90 Day Avg. Volume i3,501,3193,835,940
Last Close$15.50$167.10
52 Week Range$9.20 - $15.73$139.70 - $200.33
% from 52W High-1.46%-16.59%
All-Time High$106.60 (Nov 27, 2006)$249.27 (Dec 27, 2021)
% from All-Time High-85.46%-32.96%
Growth Metrics
Quarterly Revenue Growth0.18%0.03%
Quarterly Earnings Growth0.53%0.04%
Financial Health
Profit Margin (TTM) i-0.13%0.28%
Operating Margin (TTM) i0.25%0.35%
Return on Equity (TTM) i-0.07%0.66%
Debt to Equity (MRQ) i54.15279.59
Cash & Liquidity
Book Value per Share (MRQ)$4.55$7.84
Cash per Share (MRQ)$5.52$5.48
Operating Cash Flow (TTM) i$90.63M$2.90B
Levered Free Cash Flow (TTM) i$51.30M$1.79B
Dividends
Last 12-Month Dividend Yield iN/A1.21%
Last 12-Month Dividend iN/A$2.03

Valuation & Enterprise Metrics Analysis: Dynavax Technologies Corporation vs Zoetis Inc.

MetricDVAX (Feb 27, 2026)ZTS (Apr 13, 2026)
Price Ratios
P/E Ratio (TTM) i54.6019.58
Forward P/E i46.9715.61
PEG Ratio i0.712.81
Price to Sales (TTM) i5.515.26
Price to Book (MRQ) i3.4115.04
Market Capitalization
Market Capitalization i$1.82B$49.75B
Enterprise Value i$1.46B$56.75B
Enterprise Value Metrics
Enterprise to Revenue i4.426.00
Enterprise to EBITDA i60.3713.96
Risk & Other Metrics
Beta i0.930.97
Book Value per Share (MRQ) i$4.55$7.84

Financial Statements Comparison: Dynavax Technologies Corporation vs Zoetis Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricDVAX (2024)ZTS (2025)
Revenue/Sales i277.25M9.47B
Cost of Goods Sold i49.45M2.67B
COGS % of Revenue i17.8%28.2%
Gross Profit i227.80M6.80B
Gross Margin i82.2%71.8%
Research & Development i61.55M698.00M
Operating Income (EBIT) i-4.12M3.60B
Operating Margin i-1.5%38.0%
EBITDA i45.70M4.17B
EBITDA Margin i16.5%44.1%
Pre-Tax Income i30.86M3.36B
Pre-Tax Income % of Revenue i11.1%35.5%
Income Tax i3.55M687.00M
Income Tax % of Revenue i1.3%7.3%
Net Income (Profit) i27.31M2.67B
Profit Margin i9.9%28.2%

Balance Sheet & Liquidity Metrics

MetricDVAX (2024)ZTS (2025)
Cash & Equivalents i95.88M2.31B
Total Current Assets i848.94M6.77B
Total Current Assets % of Revenue i306.2%71.5%
Total Current Liabilities i78.63M2.24B
Total Current Liabilities % of Revenue i28.4%23.6%
Long-Term Debt i250.24M9.24B
Long-Term Debt % of Revenue i90.3%97.6%
Total Shareholders Equity i596.80M3.33B
Retained Earnings i-903.28M13.74B
Retained Earnings % of Revenue i-325.8%145.2%
Property, Plant & Equipment i39.76M288.00M

Cash Flow Statement Comparison

MetricDVAX (2024)ZTS (2025)
Operating Cash Flow i69.99M2.78B
Operating Cash Flow % of Revenue i25.2%29.3%
Capital Expenditures i-6.35MN/A
Free Cash Flow i60.16M2.28B
FCF Margin i21.7%24.1%
Debt Repayment iN/A-1.35B
Common Stock Repurchase i-100.00M-3.24B

Short Interest & Institutional Ownership Analysis

MetricDVAXZTS
Shares Short i9.79M15.12M
Short Ratio i2.813.60
Short % of Float i13.19%4.06%
Shares Outstanding i117.36M424.93M
Float Shares i100.34M421.29M
% Held by Insiders i0.75%0.15%
% Held by Institutions i101.55%101.50%
% Held by Public i-2.30%-1.65%

Dividend Analysis & Yield Comparison: Dynavax Technologies Corporation vs Zoetis Inc.

MetricDVAXZTS
Last 12-Month Dividend iN/A$2.03
Last 12-Month Dividend Yield iN/A1.21%
3-Year Avg Annual Dividend iN/A$1.80
3-Year Avg Dividend Yield iN/A0.29%
3-Year Total Dividends iN/A$5.39
Ex-Dividend DateN/AJan 20, 2026